DP2 receptor (pd2r2_human)
FAMILY
Class A (Rhodopsin) Lipid receptors Prostanoid receptors DP2 receptor
GENE
PTGDR2 (CRTH2, DL1R, GPR44)
ORGANISM
Human (Homo sapiens)
ALT. NAMES
Prostaglandin D2 receptor 2, Chemoattractant receptor-homologous molecule expressed on Th2 cells, G-protein coupled receptor 44, CD294
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
S
|
A
|
N
|
A
|
T
|
L
|
K
|
P
|
L
|
10 |
C
|
P
|
I
|
L
|
E
|
Q
|
M
|
S
|
R
|
L
|
20 |
Q
|
S
|
H
|
S
|
N
|
T
|
S
|
I
|
R
|
Y
|
30 |
TM1 | |||||||||
I
|
D
|
H
|
A
|
A
|
V
|
L
|
L
|
H
|
G
|
40 |
L
|
A
|
S
|
L
|
L
|
G
|
L
|
V
|
E
|
N
|
50 |
G
|
V
|
I
|
L
|
F
|
V
|
V
|
G
|
C
|
R
|
60 |
ICL1 | TM2 | ||||||||
M
|
R
|
Q
|
T
|
V
|
V
|
T
|
T
|
W
|
V
|
70 |
L
|
H
|
L
|
A
|
L
|
S
|
D
|
L
|
L
|
A
|
80 |
S
|
A
|
S
|
L
|
P
|
F
|
F
|
T
|
Y
|
F
|
90 |
ECL1 | |||||||||
L
|
A
|
V
|
G
|
H
|
S
|
W
|
E
|
L
|
G
|
100 |
TM3 | |||||||||
T
|
T
|
F
|
C
|
K
|
L
|
H
|
S
|
S
|
I
|
110 |
F
|
F
|
L
|
N
|
M
|
F
|
A
|
S
|
G
|
F
|
120 |
L
|
L
|
S
|
A
|
I
|
S
|
L
|
D
|
R
|
C
|
130 |
ICL2 | |||||||||
L
|
Q
|
V
|
V
|
R
|
P
|
V
|
W
|
A
|
Q
|
140 |
TM4 | |||||||||
N
|
H
|
R
|
T
|
V
|
A
|
A
|
A
|
H
|
K
|
150 |
V
|
C
|
L
|
V
|
L
|
W
|
A
|
L
|
A
|
V
|
160 |
L
|
N
|
T
|
V
|
P
|
Y
|
F
|
V
|
F
|
R
|
170 |
ECL2 | |||||||||
D
|
T
|
I
|
S
|
R
|
L
|
D
|
G
|
R
|
I
|
180 |
M
|
C
|
Y
|
Y
|
N
|
V
|
L
|
L
|
L
|
N
|
190 |
TM5 | |||||||||
P
|
G
|
P
|
D
|
R
|
D
|
A
|
T
|
C
|
N
|
200 |
S
|
R
|
Q
|
V
|
A
|
L
|
A
|
V
|
S
|
K
|
210 |
F
|
L
|
L
|
A
|
F
|
L
|
V
|
P
|
L
|
A
|
220 |
I
|
I
|
A
|
S
|
S
|
H
|
A
|
A
|
V
|
S
|
230 |
ICL3 | |||||||||
L
|
R
|
L
|
Q
|
H
|
R
|
G
|
R
|
R
|
R
|
240 |
TM6 | |||||||||
P
|
G
|
R
|
F
|
V
|
R
|
L
|
V
|
A
|
A
|
250 |
V
|
V
|
A
|
A
|
F
|
A
|
L
|
C
|
W
|
G
|
260 |
P
|
Y
|
H
|
V
|
F
|
S
|
L
|
L
|
E
|
A
|
270 |
ECL3 | TM7 | ||||||||
R
|
A
|
H
|
A
|
N
|
P
|
G
|
L
|
R
|
P
|
280 |
L
|
V
|
W
|
R
|
G
|
L
|
P
|
F
|
V
|
T
|
290 |
S
|
L
|
A
|
F
|
F
|
N
|
S
|
V
|
A
|
N
|
300 |
H8 | |||||||||
P
|
V
|
L
|
Y
|
V
|
L
|
T
|
C
|
P
|
D
|
310 |
M
|
L
|
R
|
K
|
L
|
R
|
R
|
S
|
L
|
R
|
320 |
T
|
V
|
L
|
E
|
S
|
V
|
L
|
V
|
D
|
D
|
330 |
C-term | |||||||||
S
|
E
|
L
|
G
|
G
|
A
|
G
|
S
|
S
|
R
|
340 |
R
|
R
|
R
|
T
|
S
|
S
|
T
|
A
|
R
|
S
|
350 |
A
|
S
|
P
|
L
|
A
|
L
|
C
|
S
|
R
|
P
|
360 |
E
|
E
|
P
|
R
|
G
|
P
|
A
|
R
|
L
|
L
|
370 |
G
|
W
|
L
|
L
|
G
|
S
|
C
|
A
|
A
|
S
|
380 |
P
|
Q
|
T
|
G
|
P
|
L
|
N
|
R
|
A
|
L
|
390 |
S
|
S
|
T
|
S
|
S
|
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
PGJ2, PGD2, thromboxane A2, PGE2, PGI2, PGF2α, PGD3
STRUCTURE MODELS
STRUCTURES
Found 3 structure(s) - view all details on the Structures page